Brigham and Women's Hospital Harvard Medical School
home research news contact us patients lab members

Clemens R. Scherzer, M.D.

Assistant Professor of Neurology
Harvard Medical School

Harvard NeuroDiscovery Biomarker Program

Associate Neurologist
Brigham and Women's Hospital
Massachusetts General Hospital


To cure Parkinson’s disease new drugs and diagnostics are needed. We look at a global view of gene activity in human Parkinson’s disease to discover disease genes, drug targets, and molecular biomarkers. We integrate large scale clinical studies with genome-wide expression analysis and genetic validation in Parkinson’s and other neurodegenerative diseases.

Study: Brain 'energy crisis' may spark Parkinson's
USAToday, November 3, 2010 »more

Study links Parkinson’s to brain’s tiny power factories
Boston Globe, November 2, 2010 »more

Damaged cell powerhouses linked to Parkinson's
Nature, October 6, 2010 »more

Gene Captain, PGC-1α, Abandons Mitochondria in PD
Alzheimer Research Forum, October 2010 »more

Transcriptional regulation of α-synuclein: insights from blood?
Future Neurology, March 2009 »more

Interview - Searching for biomarkers in Parkinson's disease
Biomarkers in Medicine, April, 2009 »more

News Archived